Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Clinical study

Biological therapy-related ADRs in patients with severe asthma

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Safety profiles of biological drugs used for the treatment of severe asthma are generally good but several potential safety signals have been identified, say authors of a study published in BioDrugs.
Literatur
Metadaten
Titel
Biological therapy-related ADRs in patients with severe asthma
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54698-6

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Phenobarbital

Case report

Tozinameran

Case report

Cefalexin

Case report

Antineoplastics